| Year |
Citation |
Score |
| 2018 |
Young T, Soorapanth S, Wilkerson J, Millburg L, Roberts T, Morgareidge D. The costs and value of modelling-based design in healthcare delivery: five case studies from the US. Health Systems (Basingstoke, England). 9: 253-262. PMID 32939262 DOI: 10.1080/20476965.2018.1548255 |
0.332 |
|
| 2013 |
Soorapanth S, Chick SE. Assessing prevention for positives: Cost-utility assessment of behavioral interventions for reducing HIV transmission International Series in Operations Research and Management Science. 190: 157-178. DOI: 10.1007/978-1-4614-6507-2_8 |
0.597 |
|
| 2011 |
Prabhu VS, Farnham PG, Hutchinson AB, Soorapanth S, Heffelfinger JD, Golden MR, Brooks JT, Rimland D, Sansom SL. Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis. Plos One. 6: e19936. PMID 21625489 DOI: 10.1371/Journal.Pone.0019936 |
0.426 |
|
| 2010 |
Soorapanth S, Chick SE. Cost-utility analysis of behavioral interventions for HIV-infected persons to reduce HIV transmission in the USA Proceedings - Winter Simulation Conference. 2433-2443. DOI: 10.1109/WSC.2010.5678939 |
0.605 |
|
| 2009 |
Brogan A, Soorapanth S, Donatz V, Hill A, Smets E. PIN48 COMPARATIVE COST-EFFICACY ANALYSIS OF DARUNAVIR/R AND OTHER RITONAVIR-BOOSTED PROTEASE INHIBITORS FOR FIRST-LINE TREATMENT OF HIV-I INFECTION IN GERMANY Value in Health. 12: A426. DOI: 10.1016/S1098-3015(10)75106-8 |
0.36 |
|
| 2009 |
Soorapanth S, Brogan A, Mrus J, Smets E. PIN13 COMPARATIVE COST-EFFICACY ANALYSIS OF DARUNAVIR/R FOR FIRST-LINE TREATMENT OF HIV INFECTION IN THE UNITED STATES Value in Health. 12: A112. DOI: 10.1016/S1098-3015(10)73621-4 |
0.36 |
|
| 2008 |
Desai K, Sansom SL, Ackers ML, Stewart SR, Hall HI, Hu DJ, Sanders R, Scotton CR, Soorapanth S, Boily MC, Garnett GP, McElroy PD. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. Aids (London, England). 22: 1829-39. PMID 18753932 DOI: 10.1097/Qad.0B013E32830E00F5 |
0.498 |
|
| 2006 |
Sansom SL, Anderson JE, Farnham PG, Dominguez K, Soorapanth S, Clark J, Sukalac T, Earp MJ, Bohannon B, Fowler MG. Updated estimates of healthcare utilization and costs among perinatally HIV-infected children. Journal of Acquired Immune Deficiency Syndromes (1999). 41: 521-6. PMID 16652063 DOI: 10.1097/01.Qai.0000191286.70331.7B |
0.484 |
|
| 2006 |
Soorapanth S, Sansom S, Bulterys M, Besser M, Theron G, Fowler MG. Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings. Journal of Acquired Immune Deficiency Syndromes (1999). 42: 213-21. PMID 16639346 DOI: 10.1097/01.Qai.0000214812.72916.Bc |
0.458 |
|
| 2005 |
Luh PB, Yu D, Soorapanth S, Khibnik AI, Rajamani R. A lagrangian relaxation based approach to schedule asset overhaul and repair services Ieee Transactions On Automation Science and Engineering. 2: 145-156. DOI: 10.1109/Tase.2005.844221 |
0.301 |
|
| 2003 |
Chick SE, Soorapanth S, Koopman JS. Inferring infection transmission parameters that influence water treatment decisions Management Science. 49: 920-935. DOI: 10.1287/Mnsc.49.7.920.16386 |
0.565 |
|
| 2001 |
Chick SE, Koopman JS, Soorapanth S, Brown ME. Infection transmission system models for microbial risk assessment. The Science of the Total Environment. 274: 197-207. PMID 11453296 DOI: 10.1016/S0048-9697(01)00749-5 |
0.564 |
|
| Show low-probability matches. |